临床试验/NCT05040984

NCT05040984招募中不适用

Predictors Affecting Long-term Use of Solifenacin or Mirabegron in Women With Overactive Bladder Syndrome

Far Eastern Memorial Hospital1 个研究点分布在 1 个国家目标入组 500 人开始时间: 2021年4月30日最近更新: 2023年3月29日

适应症

干预措施

试验速览

阶段: 不适用
状态: 招募中
发起方: Far Eastern Memorial Hospital
入组人数: 500
试验地点: 1
主要终点: Predictors of persistence of mirabegron versus solifenacin use

研究概览研究设计入排标准研究组 & 干预措施结局指标研究者研究点记录与标识符相似试验

研究概览

简要总结

A retrospective analysis of medical records at Far Eastern Memorial Hospital from January 2008 to May 2020 about female patients with overactive bladder syndrome, who received Solifenacin or Mirabegron as the initial treatment. Factors affecting persistence of OAB medications will be analyzed.

研究设计

研究类型: Observational
观察模型: Cohort
时间视角: Retrospective

入排标准

年龄范围: 20 Years 至 —（Adult, Older Adult）
性别: Female
接受健康志愿者: 否

入选标准

•Women with overactive bladder syndrome received solifenacin or mirabegron as the initial treatment

排除标准

•<20 year-old

研究组 & 干预措施

solifenacin

干预措施: Solifenacin Oral Tablet (Drug)

mirabegron

干预措施: Mirabegron 25mg (Drug)

结局指标

主要结局

Predictors of persistence of mirabegron versus solifenacin use

时间窗: 13 years

次要结局

未报告次要终点

研究者

发起方

Far Eastern Memorial Hospital

申办方类型

Other

责任方

Principal Investigator

主要研究者

Sheng-Mou Hsiao

Chief of Department of Obstetrics & Gynecology

Far Eastern Memorial Hospital

研究点 (1)

Loading locations...

相似试验

已完成

4 期

A Study to Evaluate Add on Effect of Solifenacin in Men With Overactive Bladder Symptoms After Tamsulosin Monotherapy for 4 WeeksOveractive Bladder

NCT00884104KYU-SUNG LEE307

已完成

3 期

A Study to Investigate How Safe and Effective Solifenacin Solution is in Treating Children/Adolescents With Symptoms of Overactive Bladder (OAB) Who Completed Study 905-CL-076Urinary Bladder, Overactive

NCT01655069Astellas Pharma Europe B.V.148

已完成

不适用

Evaluation of Adherence to Solifenacin Treatment in Overactive Bladder PatientsUrinary Bladder, OveractiveOveractive Bladder

NCT00985387Astellas Pharma Inc1,215

已完成

不适用

A Study to Evaluate Quality of Life in Patients Switched to Solifenacin From Other AntimuscarinicsUrinary Bladder, Overactive

NCT02087098Astellas Pharma Europe B.V.2,000

已完成

1 期

Single-dose Study to Assess Pharmacokinetics of Solifenacin Succinate Suspension in Children and AdolescentsUrinary Bladder, Overactive

NCT01262391Astellas Pharma Inc42